Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2012 1
2019 2
2020 10
2021 19
2022 22
2023 20
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Eptinezumab.
[No authors listed] [No authors listed] 2023 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 32697467 Free Books & Documents. Review.
Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.
Ashina M, Lanteri-Minet M, Pozo-Rosich P, Ettrup A, Christoffersen CL, Josiassen MK, Phul R, Sperling B. Ashina M, et al. Lancet Neurol. 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5. Lancet Neurol. 2022. PMID: 35716692 Clinical Trial.
Eptinezumab.
[No authors listed] [No authors listed] 2021 Jul 9. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2021 Jul 9. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 34292696 Free Books & Documents. Review.
Eptinezumab for migraine.
[No authors listed] [No authors listed] Aust Prescr. 2022 Jun;45(3):97-98. doi: 10.18773/austprescr.2022.030. Epub 2022 Apr 29. Aust Prescr. 2022. PMID: 35755991 Free PMC article. Review. No abstract available.
Eptinezumab: First Approval.
Dhillon S. Dhillon S. Drugs. 2020 May;80(7):733-739. doi: 10.1007/s40265-020-01300-4. Drugs. 2020. PMID: 32266704 Review.
Eptinezumab for the treatment of migraine.
Scuteri D, Corasaniti MT, Tonin P, Bagetta G. Scuteri D, et al. Drugs Today (Barc). 2019 Nov;55(11):695-703. doi: 10.1358/dot.2019.55.11.3069864. Drugs Today (Barc). 2019. PMID: 31840684 Review.
Eptinezumab for the treatment of migraine.
Spuntarelli V, Negro A, Luciani M, Bentivegna E, Martelletti P. Spuntarelli V, et al. Expert Opin Biol Ther. 2021 Aug;21(8):999-1011. doi: 10.1080/14712598.2021.1931678. Epub 2021 Jun 1. Expert Opin Biol Ther. 2021. PMID: 34009094 Review.
Eptinezumab for the preventive treatment of migraine.
Villar-Martínez MD, Moreno-Ajona D, Goadsby PJ. Villar-Martínez MD, et al. Pain Manag. 2021 Mar;11(2):113-121. doi: 10.2217/pmt-2020-0075. Epub 2020 Dec 7. Pain Manag. 2021. PMID: 33280422 Review.
78 results